At the time Pylos acquired the industrial site “Eli Lilly” in 2007, the site of +10 hectares was composed of 4 production and R&D buildings. The project was in a 1st stage reconverted to a mixed use business park with the main focus on biotech companies. Within a timeframe of 2 years Pylos redeveloped the entire stock of 20.000 sq.m.